The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The relationship between PIK3CA mutations and survival in patients with human epidermal growth factor receptor 2–positive breast cancer receiving pyrotinib combined with trastuzumab for neoadjuvant treatment.
 
Qiyun Shi
No Relationships to Disclose
 
Hao Tian
No Relationships to Disclose
 
Dandan Ma
No Relationships to Disclose
 
Juncheng Xuhong
No Relationships to Disclose
 
Jia Ge
No Relationships to Disclose
 
Feng Liu
No Relationships to Disclose
 
Yang Lan
No Relationships to Disclose
 
Peng Tang
No Relationships to Disclose
 
Yan Liang
No Relationships to Disclose
 
Li Chen
No Relationships to Disclose
 
Linjun Fan
No Relationships to Disclose
 
Yi Zhang
No Relationships to Disclose
 
Tao Luo
No Relationships to Disclose
 
Xiuwu Bian
No Relationships to Disclose
 
Jun Jiang
No Relationships to Disclose
 
Xiaowei Qi
No Relationships to Disclose